<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04983069</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL21_0376</org_study_id>
    <nct_id>NCT04983069</nct_id>
  </id_info>
  <brief_title>Neonatal Outcome of Children With Antenatal Colic Hyperechogenicity</brief_title>
  <acronym>COLONECHOGENE</acronym>
  <official_title>Neonatal Outcome of Children With Antenatal Colic Hyperechogenicity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Fetal colic hyper-echogenicity is a presenting symptoms for cystinuria lysinuria.&#xD;
&#xD;
      A few cases of fetuses with dibasic protein intolerance (more complex prognosis) presented&#xD;
      with colic hyper-echogenicity antenatal.&#xD;
&#xD;
      The aim of this retrospective study is to assess the outcome of fetuses with colic&#xD;
      hyperechogenicity in order to increase prenatal counseling&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Observational multicenter retrospective study from january 2011 to january 2021.&#xD;
&#xD;
      No supplementary visit, directly related to the research, will be necessary. This study does&#xD;
      not change the usual management of the patient.&#xD;
&#xD;
      Patients will be included after their usual medical check-up.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2021</start_date>
  <completion_date type="Anticipated">May 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 1, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Postnatal outcome of fetuses</measure>
    <time_frame>day 1 (End of follow up)</time_frame>
    <description>Postnatal outcome of fetuses with hyperechogenic colon.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of lysinuria/cystinuria</measure>
    <time_frame>day 1 (End of follow up)</time_frame>
    <description>Rate of lysinuria/cystinuria</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of dibasic protein intolerance</measure>
    <time_frame>day 1 (End of follow up)</time_frame>
    <description>Rate of dibasic protein intolerance</description>
  </secondary_outcome>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Colic</condition>
  <condition>Nephropathy</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Foetuses with prenatal colic hyperechogenicity&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:&#xD;
&#xD;
          -  Fetuses with prenatal colic hyperechogenicity&#xD;
&#xD;
          -  Between January 2011 and January 2021&#xD;
&#xD;
          -  Born without term limitation.&#xD;
&#xD;
        Exclusion criteria:&#xD;
&#xD;
          -  Intestinal hyperechogenicity&#xD;
&#xD;
          -  polymalformative syndrome&#xD;
&#xD;
          -  Patients Age&lt;15 years&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Florent FUCHS, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Montpellier</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Florent FUCHS, PhD</last_name>
    <phone>04 67 33 09 80</phone>
    <phone_ext>33</phone_ext>
    <email>f-fuchs@chu-montpellier.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Alexis RODRIGUEZ, resident</last_name>
    <phone>668591043</phone>
    <phone_ext>33</phone_ext>
    <email>alexis-rodriguez@chu-montpellier.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Uhmontpellier</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Florent Fuchs, PhD</last_name>
      <email>f-fuchs@chu-montpellier.fr</email>
    </contact>
    <contact_backup>
      <last_name>Alexis RODRIGUEZ</last_name>
      <phone>668591043</phone>
      <phone_ext>33</phone_ext>
      <email>alexis-rodriguez@chu-montpellier.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>July 5, 2021</study_first_submitted>
  <study_first_submitted_qc>July 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 30, 2021</study_first_posted>
  <last_update_submitted>November 12, 2021</last_update_submitted>
  <last_update_submitted_qc>November 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Gynecology-Obstetrics</keyword>
  <keyword>Ultrasound</keyword>
  <keyword>Medical genetics</keyword>
  <keyword>Pediatrics</keyword>
  <keyword>Nephropathy</keyword>
  <keyword>Colic hyperechogenicity</keyword>
  <keyword>Antenatal</keyword>
  <keyword>Lysinuria-cystinuria</keyword>
  <keyword>lysinuric protein intolerance</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Colic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>NC</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

